The mobile sleep medicine model in neurologic practice: Rationale and application
BackgroundUndiagnosed obstructive sleep apnea (OSA) is prevalent in neurological practice and significantly contributes to morbidity and mortality. OSA is prevalent in US adults and causes poor quality sleep and significant neurocognitive, cardiovascular, and cerebrovascular impairments. Timely trea...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.1032463/full |
_version_ | 1811257586270339072 |
---|---|
author | Mark I. Boulos Mark I. Boulos Mark I. Boulos Luqi Chi Oleg Y. Chernyshev Oleg Y. Chernyshev |
author_facet | Mark I. Boulos Mark I. Boulos Mark I. Boulos Luqi Chi Oleg Y. Chernyshev Oleg Y. Chernyshev |
author_sort | Mark I. Boulos |
collection | DOAJ |
description | BackgroundUndiagnosed obstructive sleep apnea (OSA) is prevalent in neurological practice and significantly contributes to morbidity and mortality. OSA is prevalent in US adults and causes poor quality sleep and significant neurocognitive, cardiovascular, and cerebrovascular impairments. Timely treatment of OSA reduces cardio-cerebrovascular risks and improves quality of life. However, most of the US population has limited systematic access to sleep medicine care despite its clinical significance.FocusWe discuss the importance of systematic screening, testing, and best-practice management of OSA and hypoventilation/hypoxemia syndromes (HHS) in patients with stroke, neurocognitive impairment, and neuromuscular conditions. This review aims to introduce and describe a novel integrated Mobile Sleep Medicine (iMSM) care model and provide the rationale for using an iMSM in general neurological practice to assist with systematic screening, testing and best-practice management of OSA, HHS, and potentially other sleep conditions.Key pointsThe iMSM is an innovative, patient-centered, clinical outcome-based program that uses a Mobile Sleep Medicine Unit—a “sleep lab on wheels”—designed to improve access to OSA management and sleep care at all levels of health care system. The protocol for the iMSM care model includes three levels of operations to provide effective and efficient OSA screening, timely testing/treatment plans, and coordination of further sleep medicine care follow-up. The iMSM care model prioritizes effective, efficient, and patient-centered sleep medicine care; therefore, all parties and segments of care that receive and provide clinical sleep medicine services may benefit from adopting this innovative approach. |
first_indexed | 2024-04-12T17:58:54Z |
format | Article |
id | doaj.art-e24ee284fd924502a8e0fd24613e2196 |
institution | Directory Open Access Journal |
issn | 1664-2295 |
language | English |
last_indexed | 2024-04-12T17:58:54Z |
publishDate | 2022-10-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Neurology |
spelling | doaj.art-e24ee284fd924502a8e0fd24613e21962022-12-22T03:22:14ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-10-011310.3389/fneur.2022.10324631032463The mobile sleep medicine model in neurologic practice: Rationale and applicationMark I. Boulos0Mark I. Boulos1Mark I. Boulos2Luqi Chi3Oleg Y. Chernyshev4Oleg Y. Chernyshev5Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaDivision of Neurology, Department of Medicine, University of Toronto, Toronto, ON, CanadaSleep Laboratory, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaWashington University School of Medicine, St. Louis, MO, United StatesSleep Medicine Division, Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United StatesOchsner LSU Health Sleep Medicine Center, Shreveport, LA, United StatesBackgroundUndiagnosed obstructive sleep apnea (OSA) is prevalent in neurological practice and significantly contributes to morbidity and mortality. OSA is prevalent in US adults and causes poor quality sleep and significant neurocognitive, cardiovascular, and cerebrovascular impairments. Timely treatment of OSA reduces cardio-cerebrovascular risks and improves quality of life. However, most of the US population has limited systematic access to sleep medicine care despite its clinical significance.FocusWe discuss the importance of systematic screening, testing, and best-practice management of OSA and hypoventilation/hypoxemia syndromes (HHS) in patients with stroke, neurocognitive impairment, and neuromuscular conditions. This review aims to introduce and describe a novel integrated Mobile Sleep Medicine (iMSM) care model and provide the rationale for using an iMSM in general neurological practice to assist with systematic screening, testing and best-practice management of OSA, HHS, and potentially other sleep conditions.Key pointsThe iMSM is an innovative, patient-centered, clinical outcome-based program that uses a Mobile Sleep Medicine Unit—a “sleep lab on wheels”—designed to improve access to OSA management and sleep care at all levels of health care system. The protocol for the iMSM care model includes three levels of operations to provide effective and efficient OSA screening, timely testing/treatment plans, and coordination of further sleep medicine care follow-up. The iMSM care model prioritizes effective, efficient, and patient-centered sleep medicine care; therefore, all parties and segments of care that receive and provide clinical sleep medicine services may benefit from adopting this innovative approach.https://www.frontiersin.org/articles/10.3389/fneur.2022.1032463/fullstrokeneuromuscular conditionsambulatory sleep testinghome sleep apnea test (HSAT)screeningmobile sleep medicine |
spellingShingle | Mark I. Boulos Mark I. Boulos Mark I. Boulos Luqi Chi Oleg Y. Chernyshev Oleg Y. Chernyshev The mobile sleep medicine model in neurologic practice: Rationale and application Frontiers in Neurology stroke neuromuscular conditions ambulatory sleep testing home sleep apnea test (HSAT) screening mobile sleep medicine |
title | The mobile sleep medicine model in neurologic practice: Rationale and application |
title_full | The mobile sleep medicine model in neurologic practice: Rationale and application |
title_fullStr | The mobile sleep medicine model in neurologic practice: Rationale and application |
title_full_unstemmed | The mobile sleep medicine model in neurologic practice: Rationale and application |
title_short | The mobile sleep medicine model in neurologic practice: Rationale and application |
title_sort | mobile sleep medicine model in neurologic practice rationale and application |
topic | stroke neuromuscular conditions ambulatory sleep testing home sleep apnea test (HSAT) screening mobile sleep medicine |
url | https://www.frontiersin.org/articles/10.3389/fneur.2022.1032463/full |
work_keys_str_mv | AT markiboulos themobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT markiboulos themobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT markiboulos themobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT luqichi themobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT olegychernyshev themobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT olegychernyshev themobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT markiboulos mobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT markiboulos mobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT markiboulos mobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT luqichi mobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT olegychernyshev mobilesleepmedicinemodelinneurologicpracticerationaleandapplication AT olegychernyshev mobilesleepmedicinemodelinneurologicpracticerationaleandapplication |